CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild-type non-small-cell lung cancer cells

Cluster of differentiation 44 (CD44) as a transmembrane glycoprotein is found to be expressed in non-small cell lung cancer (NSCLC), is significantly associated with NSLC progression, metastasis and drug resistance. This study aimed to explore whether CD44 inhibition improves the sensitivity of epid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Mol Med
Egile Nagusiak: Yin, Jianhua, Zhang, Hanyu, Wu, Xu, Zhang, Yuchen, Li, Jing, Shen, Jing, Zhao, Yueshui, Xiao, Zhangang, Lu, Lan, Huang, Chengliang, Zhang, Zhuo, Du, Fukuan, Wu, Yuanlin, Kaboli, Parham Jabbarzadeh, Cho, Chi Hin, Yuan, Dandan, Li, Mingxing
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2020
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7169661/
https://ncbi.nlm.nih.gov/pubmed/32236608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2020.4562
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak